FDA Investigator Carol Rivera Lopez, PhD
Carol Rivera Lopez, PhD has conducted inspections on 6 sites in 1 countries as of 28 Jun 2010. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
28 Jun 2010
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Carol Rivera Lopez, PhD:
Aimee J Edwin,
Albert F Peacock, PhD,
Ana P Barido,
Andrea A Branche,
Arindam Dasgupta, PhD,
Barbara A Rusin,
Barbara J Holladay,
Brandon L Mariner,
Brooke K Higgins,
Byron Ho, DVM,
Candice C Mandera,
Candice J Cortes,
Carla C Tuite,
Catherine Whiteside, PhD,
Charles A Snipes, PhD,
Charles M Kerns, BLT DO,
Chelsea W Lamm,
Christine M Whitby, CSO,
Corey K Reno,
Cynthia A Harris, MD, RN,
D'arbra R Blankenship,
Darren D Holaday,
David K Glasgow,
Dawn C Olenjack,
Dianne H Milazzo,
Dina A Tallman,
Douglas W Gronski,
Dr. Abhijit Raha, PhD,
Dr. Gopa Biswas, PhD,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dylan D Yao, MD, PhD,
Elise A Murphy,
Emest F Bizjak,
Eric S Pittman,
Gajendiran Mahadevan, PhD,
Geoffrey K Kilili,
Gifford Whitehurst, Jr,
Gregory S Larson,
Hector Jcolon Torres,
Hugh M Mcclure, II,
Huixia Zhang,
Jacqueline A O'shaughnessy, PhD,
Janet L Bowen,
Jennifer A Longie Vollom,
Jodi M Gatica,
John A Kadavil, PhD,
John J Welsh, PhD,
John Kadavil, PhD,
Joseph R Haynes,
Karen M Cooper,
Karen M Kondas,
Kenneth Nieves,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Lisa B Orr,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Martin K Yau, PhD,
Melissa J Garcia,
Michael F Skelly, PhD,
Mishelle L Harriger,
Nancy A Bellamy,
Natalie A Mickelsen, DVM,
Nathaniel R Esaw,
Niraj R Mehta, PhD,
Patrick D Stone, MS,
Robert Barron,
Sam H Haidar, PhD,
Samuel H Chan, PharmD,
Scott B Laufenberg,
Sean Y Kassim, PhD,
Sharon L Matson,
Sharon M Harold,
Sherry L Secrist, BLT DO,
Srinivas R Chennamaneni, PhD,
Sripal R Mada, PhD,
Stephanie Mangigian, MS/OSH, RN,
Stephen J Kilker,
Steven J Thurber,
Tamal K Chakraborti, PhD,
Tamika E Allen, RN,
Tara C Singh,
Tracey Asinjen Wiersma,
Traci C Kelm,
Tracy L Taras, PhD,
William D Tingley,
William H Linkroum,
Xikui Chen (nmi), PhD,
Yih Chain Huang, PhD,
Yvette Mlacour Davis
Carol Rivera Lopez, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2009 | FDA 483 | Charles River Laboratories Ashland, LLC - Form 483, 2009-10-30 |
May, 2010 | FDA 483 | Cetero Research - Form 483, 2010-05-07 |
October, 2009 | EIR | Charles River Laboratories Ashland, LLC - EIR, 2009-10-30 |
July, 2009 | FDA 483 | Covance Laboratories, Inc. - Form 483, 2009-07-22 |
July, 2010 | FDA 483 | Charles River Laboratories - Form 483, 2010-07-07 |
March, 2010 | EIR | PRACS Institute, Ltd. - EIR, 2010-03-25 |
January, 2010 | FDA 483 | PPD Development, L.P. - Form 483, 2010-01-08 |
July, 2010 | EIR | Charles River Laboratories - EIR, 2010-07-07 |
January, 2010 | EIR | PPD Development, L.P. - EIR, 2010-01-08 |
July, 2009 | EIR | Covance Laboratories, Inc. - EIR, 2009-07-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more